Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bristol-Myers Squibb CB1 antagonists reduce weight in obesity models

Nov. 11, 2009

Long-lasting responses to VB4-845 seen in patients with bladder cancer

Nov. 11, 2009

Midodrine can reverse anejaculation

Nov. 11, 2009

Azathioprine superior to mycophenolate mofetil as maintenance therapy for ANCA-AAV

Nov. 10, 2009

Pilot clinical data suggest beneficial effects of transdermal nicotine in mild cognitive impairment

Nov. 10, 2009

Subcutaneous abatacept may be delivered without methotrexate to treat RA

Nov. 10, 2009

Tesofensine effects on weight lead to phase III investigation

Nov. 10, 2009

Interim results of phase III study with CIMAvax EGF vaccine in NSCLC reported

Nov. 10, 2009

Bupropion improves hypoactive sexual desire disorder in women

Nov. 10, 2009

Phase III results show activity of omiganan 1% gel against catheter-related infections

Nov. 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.